American Society of Hematology Annual Meeting 2024 – Updates in CLL (Part 2)

from Medical News Podcast · host PeerDirect Publishing

Drs. Coombs and Shadman review CLL abstracts presented at the ASH 2024 annual meeting, including results from 2 early‑phase evaluations of BTK degraders and primary results of the ibrutinib combination cohort from the TRANSCEND CLL 004 study of the CAR T‑cell therapeutic, liso‑cel.

Episode metadata supplied by the publisher feed · Published Jan 6, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

American Society of Hematology Annual Meeting 2024 – Updates in CLL (Part 2)

0:00 13:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 13 minutes long.

When was this Medical News Podcast episode published?

This episode was published on January 6, 2025.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!